ATE96331T1 - Fr115224 enthaltende zusammensetzung fuer eine parenterale verabreichung. - Google Patents

Fr115224 enthaltende zusammensetzung fuer eine parenterale verabreichung.

Info

Publication number
ATE96331T1
ATE96331T1 AT90110339T AT90110339T ATE96331T1 AT E96331 T1 ATE96331 T1 AT E96331T1 AT 90110339 T AT90110339 T AT 90110339T AT 90110339 T AT90110339 T AT 90110339T AT E96331 T1 ATE96331 T1 AT E96331T1
Authority
AT
Austria
Prior art keywords
parenteral administration
containing composition
cyclodextrin
substance
preparing
Prior art date
Application number
AT90110339T
Other languages
English (en)
Inventor
Sotoo Asakura
Nobuto Kanagawa
Youhei Kiyota
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of ATE96331T1 publication Critical patent/ATE96331T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/813—Carrier is a saccharide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT90110339T 1989-06-02 1990-05-31 Fr115224 enthaltende zusammensetzung fuer eine parenterale verabreichung. ATE96331T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14197289 1989-06-02

Publications (1)

Publication Number Publication Date
ATE96331T1 true ATE96331T1 (de) 1993-11-15

Family

ID=15304406

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90110339T ATE96331T1 (de) 1989-06-02 1990-05-31 Fr115224 enthaltende zusammensetzung fuer eine parenterale verabreichung.

Country Status (11)

Country Link
US (1) US5093127A (de)
EP (1) EP0400637B1 (de)
JP (1) JP2987883B2 (de)
KR (1) KR910000165A (de)
AT (1) ATE96331T1 (de)
AU (1) AU644588B2 (de)
CA (1) CA2017156A1 (de)
DE (1) DE69004151T2 (de)
DK (1) DK0400637T3 (de)
ES (1) ES2059882T3 (de)
ZA (1) ZA903856B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE129409T1 (de) * 1990-12-21 1995-11-15 Fujisawa Pharmaceutical Co Neue verwendung von peptidderivat.
US5494901A (en) * 1993-01-05 1996-02-27 Javitt; Jonathan C. Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent
WO1994020126A1 (en) * 1993-03-03 1994-09-15 Fujisawa Pharmaceutical Co., Ltd. Use of peptides for the manufacture of a medicament
US5631297A (en) * 1994-07-11 1997-05-20 Pate; David W. Anandamides useful for the treatment of intraocular hypertension, ophthalmic compositions containing the same and methods of use of the same
CA2192965C (en) * 1994-07-11 2007-12-04 David W. Pate Anandamide analogue compositions and method of treating intraocular hypertension using same
US6123932A (en) * 1999-06-14 2000-09-26 The Procter & Gamble Company Deodorant compositions containing cyclodextrin odor controlling agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU181703B (en) * 1980-05-09 1983-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing aqueus solutuins of water insoluble or hardly soluble vitamines, steroides, localanesthetics, prostanoides and non-steroid and antiphlogistic agents
HU201685B (en) * 1987-04-23 1990-12-28 Chinoin Gyogyszer Es Vegyeszet For producing pharmaceutical compositions for inhalation and compositions for scenting air containing volatile active component in cyclodextrine inclusion, and air-scenting composition
GB2226023A (en) * 1988-11-29 1990-06-20 Glaxo Group Ltd Optical isomers of thromboxane antagonist prostanoids
GB8807921D0 (en) * 1988-04-05 1988-05-05 Fujisawa Pharmaceutical Co Ws-9326 & its derivatives
JPH0742313B2 (ja) * 1988-03-28 1995-05-10 日立化成工業株式会社 新規ペプチド、その塩及びペプチド性抗アレルギー剤

Also Published As

Publication number Publication date
EP0400637A3 (de) 1991-07-03
EP0400637A2 (de) 1990-12-05
DE69004151D1 (de) 1993-12-02
DE69004151T2 (de) 1994-03-24
EP0400637B1 (de) 1993-10-27
ES2059882T3 (es) 1994-11-16
JPH0386833A (ja) 1991-04-11
AU644588B2 (en) 1993-12-16
KR910000165A (ko) 1991-01-29
CA2017156A1 (en) 1990-12-02
AU5604790A (en) 1990-12-06
ZA903856B (en) 1991-05-29
US5093127A (en) 1992-03-03
DK0400637T3 (da) 1993-12-06
JP2987883B2 (ja) 1999-12-06

Similar Documents

Publication Publication Date Title
EP0326618A4 (de) Medizinische zusammensetzung, welche albumin als träger enthält, und verfahren zu deren herstellung.
FI895693A7 (fi) Parantuneen liukoisuuden omaavia kantaja/lääkeainekoostumuksia ja menetelmä niiden valmistamiseksi
GEP20074095B (en) Analogs of human insulin modified at position 29 of the b chain thereof
AR243382A1 (es) Procedimiento para preparar composiciones farmaceuticas para administracion endovenosa.
DE69021138D1 (de) Spatelförmige chirurgische Nadel.
DE3877331D1 (de) Exifon und ein wasserloesliches polymer enthaltende pharmazeutische zubereitung.
IT8920063A0 (it) Metodi per la preparazione di composizioni farmaceutiche a base di bromocriptina dotate di elevata stabilita' e prodotti derivanti.
BR9206741A (pt) Composição fluoroquímica artigo e processo de preparação da composição fluoroquímica
KR0156686B1 (en) Pharmaceutical composition comprising aryl-substituted rhodanine derivatives
FI902433A7 (fi) Menetelmä jauhemaisen polydekstroosin valmistamiseksi, joka on olennaisesti vapaa hapoista ja sitä sisältäviä koostumuksia
DE69119810D1 (de) Pyrogensorbentmittel
DE69007714D1 (de) Pharmazeutische Zubereitung mit antitumoraler Wirkung und Verfahren zur Herstellung.
FI921562A7 (fi) Gem-difosfonihapot, menetelmä niiden valmistamiseksi ja farmaseuttiset koostumukset, jotka sisältävät niitä
DE69012650D1 (de) Piperidinderivat, Verfahren zur Herstellung davon und dieses enthaltende pharmazeutische Zusammensetzung.
EP0416575A3 (en) Drug delivery compositions based on biological materials and methods for preparing such compositions
IL89504A0 (en) Diphtheria toxin derivative,process for the preparation thereof and pharmaceutical composition containing the same
ATE96331T1 (de) Fr115224 enthaltende zusammensetzung fuer eine parenterale verabreichung.
EP0484403A4 (en) Lipid a analog/immunogenic carrier conjugates and the use thereof as vaccines
ZA901543B (en) Benzoxazolinone derivatives,process for preparing them and pharmaceutical compositions containing them
IL95980A0 (en) Process for preparing n,n'-bistetrabromophthalimide)
IT8822471A0 (it) Procedimento per preparare polinucleotidi, prodotto cosi'ottenuto e preparazioni farmaceutiche contenenti il medesimo
IL95210A0 (en) 14,17alpha-etheno-and-ethanoestratrienes,process for the preparation thereof and pharmaceutical compositions containing the same
FI904229A7 (fi) Oligodendrosyyteille sytotoksinen tekijä
IT8705187A0 (it) Procedimento per preparare coniugati di metalloproteine e nuovi derivati dei coniugati stessi.
CS22690A3 (en) N,n-dialkylmonoazoniumcrownhalides and process for preparing thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee